A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure

Sylvain Thépot; Simone Boehrer; Valérie Seegers; Thomas Prébet; Odile Beyne‐Rauzy; Eric Wattel; Jacques Delaunay; Emmanuel Raffoux; Mathilde Hunault; Éric Jourdan; Fatiha Chermat; Marie Sébert; Guido Guido Kroemer; Pierre Fenaux; Lionel Adès

doi:10.1016/j.leukres.2014.09.014

Related publications

Article2008

Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A preclinical comparison

Simone Boehrer, Lionel Adès, Lorenzo Galluzzi, Nicolas Tajeddine, Maximilien Tailler, Claude Gardin, Stéphane de Botton, Pierre Fenaux, Guido Guido Kroemer

Article2012

Erlotinib antagonizes ABC transporters in acute myeloid leukemia

Élodie Lainey, Marie Sébert, Sylvain Thépot, Marie Scoazec, Cyrielle Bouteloup, Carole Leroy, Stéphane de Botton, Lorenzo Galluzzi, Pierre Fenaux, Guido Guido Kroemer

Article2012

Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia

Élodie Lainey, A. Wolfromm, Nicolas Marie, David Enot, Marie Scoazec, Cyrielle Bouteloup, Carole Leroy, J-B Micol, Stéphane de Botton, Lorenzo Galluzzi, Pierre Fenaux, Guido Guido Kroemer

Article2022

MDS-445 Magrolimab In Combination With Azacitidine for Patients With Untreated Higher-Risk Myelodysplastic Syndromes (HR MDS): 5F9005 Phase 1b Study Results

David A. Sallman, Monzr M. Al Malki, Adam Asch, Eunice S. Wang, Joseph G. Jurcic, Terrence Bradley, Ian W. Flinn, Daniel A. Pollyea, Suman Kambhampati, Tiffany Tanaka, Joshua F. Zeidner, Guillermo Garcia‐Manero, Deepa Jeyakumar, Lin Gu, Anderson Tan, Mark P. Chao, Carol O’Hear, Indu Lal, Paresh Vyas, Naval Daver

Article2008

ATM mediates constitutive NF-κB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia

Jennifer Grosjean-Raillard, Maximilien Tailler, Lionel Adès, Jean‐Luc Perfettini, Claire Fabre, Thomas Braun, Stéphane de Botton, Pierre Fenaux, Guido Guido Kroemer